| Carrie Snyder, | |
|
2500 California Plz, Hlsb Rm 202, Omaha, NE 68178-0133 | |
| (402) 280-2942 | |
| (402) 280-1734 |
| Full Name | Carrie Snyder |
|---|---|
| Gender | Female |
| Speciality | Clinical Nurse Specialist - Oncology |
| Location | 2500 California Plz, Omaha, Nebraska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043620917 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SX0200X | Clinical Nurse Specialist - Oncology | 114129 (Nebraska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Carrie Snyder, 2500 California Plz, Hlsb Rm 202, Omaha, NE 68178-0133 Ph: (402) 280-2942 | Carrie Snyder, 2500 California Plz, Hlsb Rm 202, Omaha, NE 68178-0133 Ph: (402) 280-2942 |
News Archive
Technology for analyzing gene expression must be standardized among laboratories and across platforms around the world to support this age of human genome exploration, an Oregon Health & Science University researcher says.
Durata Therapeutics, Inc. today announced preliminary, top-line results for its DISCOVER 1 ("Dalbavancin for Infections of the Skin COmpared to Vancomycin at an Early Response") Phase 3 study of dalbavancin, which is under investigation for the treatment of acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible gram-positive bacteria, including MRSA (methicillin resistant Staphylococcus aureus).
Results of an advanced clinical trial of an antiretroviral-based microbicide candidate are being announced at the International AIDS Conference in Vienna, Austria. The CAPRISA 004 trial, which tested the safety and effectiveness of 1% tenofovir gel among nearly 900 women at two sites in South Africa, found that using the gel before and after sex provided moderate protection against sexually transmitted HIV.
Researchers have discovered a reason why smoking greatly increases the risk of heart disease and stroke. Nicotine promotes insulin resistance, also called prediabetes, which is a risk factor for cardiovascular disease, according to the new study, which was presented at The Endocrine Society's 91st Annual Meeting in Washington, D.C.
While estimates of the overall risk of a thrombotic (blood clot) event recurrence vary, reports on contributing factors are contradictory, according to background information in the article. Knowledge of the risk of a thrombotic event recurrence and its determinants is relevant for clinical policy regarding screening for thrombophilia (increased risk for blood clot), duration of anticoagulant treatment, and treatment strategies in circumstances of increased risk.
› Verified 1 days ago
Sharon K Baker, APRN Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 988095 Nebraska Medical Ctr, Omaha, NE 68198 Phone: 402-559-9800 Fax: 402-559-9840 | |
Christina J Vejnovich, DNP, APRN-CNS Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 8303 Dodge St, Omaha, NE 68114 Phone: 402-354-8744 | |
Leigh K Cook, APRN Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 42nd @ Dewey St, Omaha, NE 68105 Phone: 402-552-6007 Fax: 402-552-6035 | |
Kerry Lynn Petersen, APRN Clinical Nurse Specialist Medicare: Medicare Enrolled Practice Location: 987440 Nebraska Medical Ctr, Neonatal Intensive Care Unit, Omaha, NE 68198 Phone: 402-559-4442 | |
Kimberly Ann Vaughan, APRN Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 119 N 51st St Ste 200, Omaha, NE 68132 Phone: 402-932-8020 Fax: 402-905-3042 | |
Shelley Clare Hultman, APRN-CNS Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 8303 Dodge St, Omaha, NE 68114 Phone: 140-235-4443 |